New Research Sheds Light on How Precancerous Lesions Form in the Pancreas - Summary - MDSpire
Feature

New Research Sheds Light on How Precancerous Lesions Form in the Pancreas

Discoveries about two metabolic enzymes could point the way to biomarkers, opportunities to prevent cancer.

  • May 11, 2026

  • 3 min

Share

Research led by Dr. Megan Radyk at Roswell Park reveals insights into pancreatic cancer prevention through the study of metabolic enzymes. Published in Nature Metabolism, the preclinical study shows that impaired functions of glucose-6-phosphate dehydrogenase (G6PD) and malic enzyme 1 (ME1) are linked to the progression of precancerous lesions in the pancreas, which could enable early detection and intervention strategies. Understanding these metabolic changes may ultimately help identify biomarkers and therapeutic approaches to combat this aggressive cancer.

Original Source(s)

New Research Sheds Light on How Precancerous Lesions Form in the Pancreas

  • May 11, 2026

Related Content

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min
Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable

Team shows BCL-2 promotes treatment resistance, uncovering strategy for making tumors respond to treatment.

  • by

  • May 11, 2026

  • 4 min
Roswell Park Experts Highlight Untapped Potential of CDK Inhibitor Cancer Therapy

Worldwide, more than a million breast cancer patients have been treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, which slow or stop the uncontrolled multiplication of cancer cells.

  • by

  • May 11, 2026

  • 3 min